| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
10,11- methylenedioxy- N- propylnoraporphine
1
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: dopaminergic prodrug; RN given refers to parent cpd(d)-isomer
Also Known As:10,11-methylenedioxy-N-propylnoraporphine monohydrochloride, (R)-isomer; MDO-NPA; 6H-Benzo(de)-1,3-benzodioxolo(4,5-g)quinoline, 6a,7,8,9-tetrahydro-7-propyl-, (R)-
Bio-Agent Context: Research Results
Related Diseases
| 1. | Catalepsy
10/01/1982
- "The effects of MDO-NPA on general activity were biphasic: larger doses stimulated activity: smaller doses markedly inhibited it and induced catalepsy"
Get all the results and reference details, order at left... |
| 1 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |